Biomedicine therapy targets only parts of two hot-pattern clusters: I-kappa B kinase/NF-κB and mRNA splicing were targeted by MTX and SSZ and fatty acid metabolism involved in hot pattern RA could not be targeted by MTX and SSZ [26]. The gene discussed is CHUK; the disease is rheumatoid arthritis.